Plasma citrulline levels are increased in patients with multiple sclerosis

Journal of the Neurological Sciences - Tập 387 - Trang 174-178 - 2018
Maxime Vande Vyver1, Roel Beelen2, Jacques De Keyser1,3, Guy Nagels1,4,5, Anne-Marie Van Binst6, Christiaan Verborgh7, Miguel D'haeseleer1,4
1Department of Neurology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Center for Neurosciences, Brussels, Belgium
2Department of Cardiovascular and Thoracic Surgery, Onze-Lieve-Vrouw Ziekenhuis, Campus Aalst, Aalst, Belgium
3Department of Neurology, Universitair Medisch Centrum Groningen, Groningen, The Netherlands
4Nationaal Multiple Sclerose Centrum, Melsbroek, Belgium
5Faculté de Psychologie et des Sciences de l'Education, Mons, Belgium
6Department of Radiology, Universitair Ziekenhuis Brussel, Brussels, Belgium
7Department of Aenesthesiology, Universitair Ziekenhuis Brussel, Brussels, Belgium

Tài liệu tham khảo

Compston, 2002, Multiple sclerosis, Lancet, 359, 1221, 10.1016/S0140-6736(02)08220-X Boggs, 2006, Myelin basic protein: a multifunctional protein, Cell. Mol. Life Sci., 63, 1945, 10.1007/s00018-006-6094-7 Korn, 2008, Pathophysiology of multiple sclerosis, J. Neurol., 255, 2, 10.1007/s00415-008-6001-2 Harauz, 2004, Myelin basic protein — diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis, Micron, 35, 503, 10.1016/j.micron.2004.04.005 Harauz, 2007, A tale of two citrullines — structural and functional aspects of myelin basic protein deimination in health and disease, Neurochem. Res., 32, 137, 10.1007/s11064-006-9108-9 Moscarello, 1994, Myelin in multiple sclerosis is developmentally immature, J. Clin. Invest., 94, 146, 10.1172/JCI117300 Wood, 1996, Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein, Ann. Neurol., 40, 18, 10.1002/ana.410400106 Oguz, 2009, Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis, AJNR Am. J. Neuroradiol., 30, 716, 10.3174/ajnr.A1425 Breuillard, 2015, Citrulline and nitrogen homeostasis: an overview, Amino Acids, 47, 685, 10.1007/s00726-015-1932-2 Polman, 2011, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann. Neurol., 69, 292, 10.1002/ana.22366 Zamboni, 2010, The chronic cerebrospinal venous insufficiency syndrome, Phlebology, 25, 269, 10.1258/phleb.2010.009083 Zamboni, 2009, Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 80, 392, 10.1136/jnnp.2008.157164 Kelm, 1998, Nitric oxide metabolism and breakdown, Biochim. Biophys. Acta, 1411, 273, 10.1016/S0005-2728(99)00020-1 Moshage, 1995, Nitrite and nitrate determinations in plasma: a critical evaluation, Clin. Chem., 41, 892, 10.1093/clinchem/41.6.892 Wang, 2013, Stability and reproducibility of the measurement of plasma nitrate in large epidemiologic studies, N. Am. J. Med. Sci., 6, 82 Jain, 2015, Clinical automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images, Neuroimage Clin., 8, 367, 10.1016/j.nicl.2015.05.003 Kurtzke, 1983, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 33, 1444, 10.1212/WNL.33.11.1444 Roxburgh, 2005, Multiple sclerosis severity score using disability and disease duration to rate disease severity, Neurology, 64, 1144, 10.1212/01.WNL.0000156155.19270.F8 Tizianello, 1980, Renal metabolism of amino acids and ammonia in subjects with normal nrenal function and in patients with chronic renal insufficiency, J. Clin. Invest., 65, 1162, 10.1172/JCI109771 Rabier, 1995, Metabolism of citrulline in man, Amino Acids, 9, 299, 10.1007/BF00807268 Collins, 2007, Watermelon consumption increases plasma arginine concentrations in adults, Nutrition, 23, 261, 10.1016/j.nut.2007.01.005 Curis, 2007, Citrulline and the gut, Curr. Opin. Clin. Nutr. Metab. Care, 10, 620, 10.1097/MCO.0b013e32829fb38d Crenn, 2000, Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans, Gastroenterology, 119, 1496, 10.1053/gast.2000.20227 Jones, 1979, Morphological and biochemical findings in jejunal biopsies from patients with multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 42, 402, 10.1136/jnnp.42.5.402 Bateson, 1979, Jejunal morphology in multiple sclerosis, Lancet, 313, 1108, 10.1016/S0140-6736(79)91790-2 Tsuei, 2005, Supplemental enteral arginine is metabolized to ornithine in injured patients, J. Surg. Res., 123, 17, 10.1016/j.jss.2004.07.006 Buijs, 2014, Intravenous glutamine supplementation enhances renal de novo arginine synthesis in humans: a stable isotope study, Am. J. Clin. Nutr., 100, 1385, 10.3945/ajcn.113.081547 Déchelotte, 1991, Absorption and metabolic effects of enterally administered glutamine in humans, Am. J. Phys., 260, 677 Chuang, 2006, Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis, Clin. Chim. Acta, 364, 209, 10.1016/j.cccn.2005.07.001 Lau, 2000, Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients, J. Clin. Invest., 105, 1217, 10.1172/JCI7199 Leonard, 2002, Urea cycle disorders, Semin. Neonatol., 7, 27, 10.1053/siny.2001.0085 Smith, 2002, The role of nitric oxide in multiple sclerosis, Lancet Neurol., 1, 232, 10.1016/S1474-4422(02)00102-3 Giovannoni, 1998, The potential role of nitric oxide in multiple sclerosis, Mult. Scler., 4, 212, 10.1177/135245859800400323 Ljubisavljevic, 2014, The importance of nitric oxide and arginase in the pathogenesis of acute neuroinflammation: are those contra players with the same direction?, Neurotox. Res., 26, 392, 10.1007/s12640-014-9470-3 Rejdak, 2004, CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis, Neurology, 63, 1439, 10.1212/01.WNL.0000142043.32578.5D Danilov, 2003, Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis, J. Neuroimmunol., 136, 112, 10.1016/S0165-5728(02)00464-2 Koch, 2008, Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis, Mult. Scler., 14, 159, 10.1177/1352458507082075 Ramsaransing, 2004, Peripheral blood leukocyte NO production in MS patients with a benign vs progressive course, Neurology, 62, 239, 10.1212/01.WNL.0000103239.72937.AD Sarchielli, 1997, Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis, J. Neuroimmunol., 80, 76, 10.1016/S0165-5728(97)00136-7 Lopez-Moratalla, 1997, Monocyte inducible nitric oxide synthase in multiple sclerosis: regulatory role of nitric oxide, Nitric Oxide Biol. Chem., 1, 95, 10.1006/niox.1996.0111 Cao, 1999, Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein, Biochemistry, 38, 6157, 10.1021/bi982960s Whitaker, 1998, Myelin basic protein in cerebrospinal fluid and other body fluids, Mult. Scler., 4, 16, 10.1177/135245859800400105